An endocannabinoid boost to immunity via anti-inflammatory effect with PEA – white paperAn endocannabinoid boost to immunity via anti-inflammatory effect with PEA – white paper
Download this white paper and learn about the endocannabinoid system and how Palmitoylethanolamide (PEA) provides specific benefits to this system and can boost a healthy immune response via anti-inflammatory pathways.
September 15, 2020
Sponsored by Gencor
Inflammation is a normal biological response to injury and other insults and invaders to the body. However, in some situations, with chronic or extreme stressors present, an imbalance in the relationship between pro-inflammatory and anti-inflammatory mediators may occur. An unhealthy response may lead to chronic inflammation and create lasting damage.
Palmitoylethanolamide (PEA), is a fatty acid amide that has demonstrated a functional ability to effectively address various inflammatory mechanisms that develop and effect the chronic pain state. Additionally, PEA exhibits a multifaceted immune response due to its unique mechanism of actions that target multiple pathways at different sites, working synergistically to produce therapeutic effects, including clinically validated immune function modulations related to specified endocannabinoid receptors.
Download this white paper and learn about PEA, its biochemistry and mechanism of action, and discover more about the clinical research history leading to today’s findings.
You May Also Like
Sep 28, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Probi study finds subjects’ brains worked better under stress with probioticSep 29, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023